Government of Canada establishes Advisory Group to help Canadians living with rare diseases
Two of the CRDN’s Steering Committee members, representing rare disease patient groups, are actively contributing to the Implementation Advisory Group (IAG) for the National Strategy for Drugs for Rare Diseases.